Skip to main content
. Author manuscript; available in PMC: 2009 Oct 5.
Published in final edited form as: Mol Cancer Ther. 2008 Jul;7(7):2212–2223. doi: 10.1158/1535-7163.MCT-07-2409

Fig. 3. HNK modulates c-FLIP levels (A and B) and the levels of other apoptosis-related proteins (C).

Fig. 3

The given cell lines were treated with 25 μM (H157) or 30 μM (H226 and A549) HNK for the indicated times (A) or with the indicated concentrations of HNK for 6 h (B) or for 3 h and 12 h as indicated (C). After the treatments, the cell lines were subjected to preparation of whole-cell protein lysates and subsequent Western blot analysis for detection of the indicated proteins.